Follow on

The Cyrex System™

Each Patient Is Unique With Different Testing Needs

We will Customized Testing Specific to You.

AUTOIMMUNE DISORDERS: A GROWING CONCERN- WE CAN HELP

  • Approximately 50 million Americans, 20 Percent of the population or one in five people, suffer from autoimmune diseases.
  • Symptoms cross many specialties and can affect all body organs.
  • Medical education provides minimal learning about autoimmune disease.
  • Specialists are generally unaware of interrelationships among the different autoimmune diseases or advances in treatment outside their own specialty area.
  • Initial symptoms are often intermittent and unspecific until the disease becomes acute.
  • Research is generally disease-specific and limited in scope. More information-sharing and crossover among research projects on different autoimmune diseases is needed.

Cyrex is focused on the fast growing health issues of autoimmune disorders now affecting tens of millions of people in the United States. Cyrex test panels are designed to evaluate your immune reactions using a proprietary, advanced technology.

Autoimmune disease testing and Triggers 4
Autoimmune disease testing and Triggers 3

As a CLIA licensed clinical laboratory, our innovative tests provide advanced clinical tools to identify and measure immune reactiviy and possible autoimmune reactivity that can affect multiple tissues such as:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cognitive Health

Identify and address the early signs of 
Alzheimer’s disease.

Recommended if you:

  • Are interested in preventing the development of Alzheimer’s disease or other neurological disorder.
  • Are exhibiting early signs of Alzheimer’s disease or other neurological disorder.
  • Have been diagnosed with Alzheimer’s disease.
  • Have a history of gastrointestinal disorders and/or diabetes.
  • Played high-impact sports.
  • Are immunoreactive against specific pathogens, chemicals and foods.

Alzheimer’s LINX – Alzheimer’s-Associated Immune Reactivity

Autoimmune disease testing and Triggers 15
Autoimmune disease testing and Triggers 16

Essential Barriers

Evaluation of the intestinal and blood-brain barrier integrity. When there is a a breach in essential defense barriers, the body is at risk for developing environmentally-induced autoimmunity.  

Recommended if you:

  • Are interested in preventing the development of Alzheimer’s disease or other neurological disorder. Array 2, 20 or 22
  • Are exhibiting early signs of Alzheimer’s disease or other neurological disorder. Array 20
  • Have been diagnosed with Alzheimer’s disease. Array 2, 20 or 22.
  • Have a history of gastrointestinal disorders and/or diabetes. Array 2 or 22
  • Played high-impact sports- Array 20.
  • Are immuno-reactive against specific pathogens, chemicals and foods.

Array 2 – Intestinal Antigenic Permeability Screen­™
Array 20 – Blood-Brain Barrier™
Array 22 – Irritable Bowel/SIBO Screen™

Predictive Antibodies

 Identify autoimmune reactivity at its early stages. Measures predictive autoantibodies, some of which can appear up to 10 years before any clinical symptoms. Efficiently and economically assesses possible tissue damage to multiple organs of the body.

Recommended if you:

  • Have a diagnosed autoimmune disorder, as there is a 25% chance of developing another condition 
  • Have chronic increased intestinal permeability, which is the gateway for environmentally-induced autoimmune disorders

Array 5 – Multiple Autoimmune Reactivity Screen™
Array 6 – Diabetes Autoimmune Reactivity Screen™
Array 7 – Neurological Autoimmune Reactivity Screen™
Array 7X – Neurological Autoimmune Reactivity Screen™ – Expanded
Array 8 – Joint Reactivity Screen™

Autoimmune disease testing and Triggers 20
Autoimmune disease testing and Triggers 18

Environmental Triggers

Identifies immune reactivity to environmental triggers which include dietary proteins, chemicals and heavy metals.

Recommended if you:

  • Have non-responsive GI symptoms.
  • Present multiple symptom complaints (including Chronic Fatigue Syndrome and Fibromyalgia).
  • Suffer from depression or neuro-autoimmunity.

Mucosal Immune

The first array to encompass the Cyrex System measuring both SIgA and SIgM

GAM assesses overall production of Immunoglobulin G, Immunoglobulin A and Immunoglobulin M in the body—an important measurement of general immunity. Total immunoglobulins testing can be a strong indicator of a disease or condition.

Recommended to verify:

  • Current status of your immune system
  • Antibody production

Array 14 – Mucosal Immune Reactivity Screen™

Autoimmune disease testing and Triggers 19

The Immune Load Reduction™ System

What is Your Immune System Load™?
You wouldn’t know unless you Get Tested. 
We help you identify key challenges to your immune system so you can reduce the immune load.
Autoimmune disease testing and Triggers 5
Autoimmune Disease Testing And Triggers 21

Alzheimer’s LINX — 
Alzheimer’s – Associated Immune Reactivity

Alzheimer’s LINX makes it easier to see the route of pathogenesis leading to cognitive decline, and devise strategies to stop it. By addressing Blood-Brain Barrier (BBB) breakdown, identifying and removing triggers and enhancing neuronal regeneration, one might be able to win the war on cognitive decline.
Autoimmune Disease Testing And Triggers 22

Total Serum IgG/IgA/IgM (GAM)

Acts as a first line of defense before Predictive Antibodies, Barrier Permeability and Environmental Triggers can influence autoimmune reactivity. 

 
Autoimmune Disease Testing And Triggers 23

Array 2 — Intestinal Antigenic Permeability Screen

Measure intestinal permeability to large molecules which inflame the immune system and identify the damaging route through the intestinal barrier.

 

 

 

 

test2 3

Array 20 — Blood-Brain Barrier Permeability

Early investigation of contact sports-related Traumatic Brain Injury, evaluation of the Blood-Brain Barrier by stress, trauma or environmental triggers.
 
 
test2 4

Array 22 — Irritable Bowel/SIBO Screen

Assess IgG, IgA and IgM antibodies to bacterial cytotoxins and to cytoskeletal proteins for an accurate measurement of bacterial overgrowth and damage to the intestinal barrier.

 

 

 

test2 5

Array 3X — Wheat/Gluten Proteome Reactivity & Autoimmunity

An expanded panel of the Wheat/Gluten reactivity testing with the introduction of 4 new antigens.
 
 
 
test2 6

Array 4 — Gluten-Associated Crosss-Reactive Foods & Foods Sensitivity

Identify dietary proteins to the gluten sensitive or celiac disease patient and detect cross-reactive foods.
 
test2 7

Array 10, 10-90 and 10-90X —
Multiple Food Immune Reactivity Screen

Evaluate immune reactions to foods, raw and/or modified, food enzymes, lectins and artificial food additives, including meat glue, colorings and gums.
 
test2 8

Array 11 — Chemical Immune Reactivity Screening               

 
Identify loss of immune tolerance and assist in setting guidelines for the avoidance of chemicals to reduce the risk of igniting the autoimmune process.
 
test2 9

Array 12 — Pathogen-Associated Immune Reactivity Screen

Pathogen Reactivity. Fungi, Bacterium, Virus immune response to latent pathogens.
 
 
test2 10

Array 5 — Multiple Autoimmune Reactivity Screen

Measure predictive antibodies up to ten years before the clinical onset of disease and assess possible tissue damage to multiple organs of the body.
test2 11

Array 6 — Diabetes Autoimmune Reactivity Screen

Assist in the early detection of autoimmune processes of Type 1 Diabetes, impaired blood sugar metabolism and Metabolic Syndrome.
 
test2 12

Array 7 — Neurological Autoimmune Reactivity Screen

Assist in the early detection of 
neuro-autoimmunity, evaluate autoimmune response and assist in monitoring effectiveness of related treatment protocols. 
 
test2 12

Array 7X — Neurological Autoimmune Reactivity Screen – Expanded

Assist in the early detection of 
neuro-autoimmunity, evaluate autoimmune response and assist in monitoring effectiveness of related treatment protocols.
test2 13

Array 8 — Joint Autoimmune Reactivity Screen

Assist in early detection of mixed connective tissue disorders and monitor the effectiveness of related treatment protocols.
 
 
test2 14

Array 14 — Mucosal Immune Reactivity Screen

Acts as a first line of defense before Predictive Antibodies, Barrier Permeability and Reactivity Triggers can influence autoimmune reactivity.